ACE2 and COVID-19: The mechanisms linking comorbidities to increased COVID-19 severity are not fully understood but may involve increased expression of the Angiotensin-Converting Enzyme 2 protein, the primary receptor that SARS-CoV-2 uses to enter human cells [28,29].